Drug Shortage Report for SANDOZ IRBESARTAN HCT

Last updated on 2020-05-11 History
Report ID 73144
Drug Identification Number 02337428
Brand name SANDOZ IRBESARTAN HCT
Common or Proper name IRBESARTAN HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-10-29
Estimated end date 2020-06-12
Actual end date
Shortage status Actual shortage
Updated date 2020-05-11
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v34 2020-05-11 French Compare
v33 2020-05-11 English Compare
v32 2020-05-04 French Compare
v31 2020-05-04 English Compare
v30 2020-04-06 French Compare
v29 2020-04-06 English Compare
v28 2020-03-30 French Compare
v27 2020-03-30 English Compare
v26 2020-02-15 French Compare
v25 2020-02-15 English Compare
v24 2020-01-08 French Compare
v23 2020-01-08 English Compare
v22 2019-12-10 French Compare
v21 2019-12-10 English Compare
v20 2019-11-18 French Compare
v19 2019-11-18 English Compare
v18 2019-10-15 French Compare
v17 2019-10-15 English Compare
v16 2019-06-12 French Compare
v15 2019-06-12 English Compare

Showing 1 to 20 of 34